1-7 of 7
Santiago Montes-Moreno
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Ibrutinib in Combination with R-GemOx in Patients with Relapsed or Refractory Diffuse Large B-cell Lymphoma of Nongerminal Center B-cell–like Type: Phase II Clinical Trial of the Spanish GELTAMO Group

Beatriz Rey-Búa, Carlos Grande, José J. Sánchez Blanco, Pau Abrisqueta, Antonio Gutiérrez, Ángel Ramírez Páyer, Eva Giné, Izaskun Zeberio Etxetxipia, Maria J. Terol, Fátima de la Cruz Vicente, Rafel Andreu, Maria J. Ramirez, Adolfo de la Fuente, Maria C. Viguria, María J. Peñarrubia, Ana Jiménez-Ubieto, Santiago Montes-Moreno, Armando López-Guillermo, María D. Caballero, Alejandro Martín García-Sancho
Journal: Clinical Cancer Research
Clin Cancer Res (2024) 30 (17): 3704–3714.
https://doi.org/10.1158/1078-0432.CCR-24-0183
Published: 03 September 2024
View article titled, Ibrutinib in Combination with R-GemOx in Patients with Relapsed or Refractory Diffuse Large B-cell Lymphoma of Nongerminal Center B-cell–like Type: Phase II Clinical Trial of the Spanish GELTAMO Group
Open the PDF for Ibrutinib in Combination with R-GemOx in Patients with Relapsed or Refractory Diffuse Large B-cell Lymphoma of Nongerminal Center B-cell–like Type: Phase II Clinical Trial of the Spanish GELTAMO Group in another window
Includes: Supplementary data
Journal Articles

Clinical and Biologic Significance of MYC Genetic Mutations in De Novo Diffuse Large B-cell Lymphoma

Zijun Y. Xu-Monette, Qipan Deng, Ganiraju C. Manyam, Alexander Tzankov, Ling Li, Yi Xia, Xiao-xiao Wang, Dehui Zou, Carlo Visco, Karen Dybkær, Jun Li, Li Zhang, Han Liang, Santiago Montes-Moreno, April Chiu, Attilio Orazi, Youli Zu, Govind Bhagat, Kristy L. Richards, Eric D. Hsi, William W.L. Choi, J. Han van Krieken, Jooryung Huh, Maurilio Ponzoni, Andrés J.M. Ferreri, Ben M. Parsons, Michael B. Møller, Sa A. Wang, Roberto N. Miranda, Miguel A. Piris, Jane N. Winter, L. Jeffrey Medeiros, Yong Li, Ken H. Young
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (14): 3593–3605.
https://doi.org/10.1158/1078-0432.CCR-15-2296
Published: 14 July 2016
View article titled, Clinical and Biologic Significance of <em>MYC</em> Genetic Mutations in <em>De Novo</em> Diffuse Large B-cell Lymphoma
Open the PDF for Clinical and Biologic Significance of <em>MYC</em> Genetic Mutations in <em>De Novo</em> Diffuse Large B-cell Lymphoma in another window
Includes: Supplementary data
Journal Articles

Clinical Implications of Phosphorylated STAT3 Expression in De Novo Diffuse Large B-cell Lymphoma

Chi Young Ok, Jiayu Chen, Zijun Y. Xu-Monette, Alexandar Tzankov, Ganiraju C. Manyam, Ling Li, Carlo Visco, Santiago Montes-Moreno, Karen Dybkær, April Chiu, Attilio Orazi, Youli Zu, Govind Bhagat, Kristy L. Richards, Eric D. Hsi, William W.L. Choi, J. Han van Krieken, Jooryung Huh, Xiaoying Zhao, Maurilio Ponzoni, Andrés J.M. Ferreri, Francesco Bertoni, John P. Farnen, Michael B. Møller, Miguel A. Piris, Jane N. Winter, L. Jeffrey Medeiros, Ken H. Young
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (19): 5113–5123.
https://doi.org/10.1158/1078-0432.CCR-14-0683
Published: 30 September 2014
View article titled, Clinical Implications of Phosphorylated STAT3 Expression in <em>De Novo</em> Diffuse Large B-cell Lymphoma
Open the PDF for Clinical Implications of Phosphorylated STAT3 Expression in <em>De Novo</em> Diffuse Large B-cell Lymphoma in another window
Includes: Supplementary data
Journal Articles

Predicting sarcoma-patients response to trabectedin treatment with molecular markers detected by immunohistochemistry.

Juan Carlos Tercero, Jose Jimeno, Nerea Martinez, Santiago Montes-Moreno, Socorro M. Rodriguez-Pinilla, Margarita Sanchez-Beato
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (19_Supplement): B8.
Published: 15 August 2014
View article titled, Predicting sarcoma-patients response to trabectedin treatment with molecular markers detected by immunohistochemistry.
Journal Articles

Prevalence and Clinical Implications of Epstein–Barr Virus Infection in De Novo Diffuse Large B-Cell Lymphoma in Western Countries

Chi Young Ok, Ling Li, Zijun Y. Xu-Monette, Carlo Visco, Alexander Tzankov, Ganiraju C. Manyam, Santiago Montes-Moreno, Karen Dybaer, April Chiu, Attilio Orazi, Youli Zu, Govind Bhagat, Jiayu Chen, Kristy L. Richards, Eric D. Hsi, William W. L. Choi, J. Han van Krieken, Jooryung Huh, Weiyun Ai, Maurilio Ponzoni, Andrés J.M. Ferreri, John P. Farnen, Michael B. Møller, Carlo E. Bueso-Ramos, Roberto N. Miranda, Jane N. Winter, Miguel A. Piris, L. Jeffrey Medeiros, Ken H. Young
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (9): 2338–2349.
https://doi.org/10.1158/1078-0432.CCR-13-3157
Published: 30 April 2014
View article titled, Prevalence and Clinical Implications of Epstein–Barr Virus Infection in <em>De Novo</em> Diffuse Large B-Cell Lymphoma in Western Countries
Open the PDF for Prevalence and Clinical Implications of Epstein–Barr Virus Infection in <em>De Novo</em> Diffuse Large B-Cell Lymphoma in Western Countries in another window
Includes: Supplementary data
Journal Articles

NIK Controls Classical and Alternative NF-κB Activation and Is Necessary for the Survival of Human T-cell Lymphoma Cells

Lina Odqvist, Margarita Sánchez-Beato, Santiago Montes-Moreno, Esperanza Martín-Sánchez, Raquel Pajares, Lydia Sánchez-Verde, Pablo L. Ortiz-Romero, Jose Rodriguez, Socorro M. Rodríguez-Pinilla, Francisca Iniesta-Martínez, Juan Carlos Solera-Arroyo, Rafael Ramos-Asensio, Teresa Flores, Javier Menarguez Palanca, Federico García Bragado, Purificación Domínguez Franjo, Miguel A. Piris
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (9): 2319–2330.
https://doi.org/10.1158/1078-0432.CCR-12-3151
Published: 30 April 2013
View article titled, NIK Controls Classical and Alternative NF-κB Activation and Is Necessary for the Survival of Human T-cell Lymphoma Cells
Open the PDF for NIK Controls Classical and Alternative NF-κB Activation and Is Necessary for the Survival of Human T-cell Lymphoma Cells in another window
Includes: Supplementary data
Journal Articles

A Unifying Microenvironment Model in Follicular Lymphoma: Outcome Is Predicted by Programmed Death-1–Positive, Regulatory, Cytotoxic, and Helper T Cells and Macrophages

Björn Engelbrekt Wahlin, Mohit Aggarwal, Santiago Montes-Moreno, Luis Francisco Gonzalez, Giovanna Roncador, Lidia Sanchez-Verde, Birger Christensson, Birgitta Sander, Eva Kimby
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (2): 637–650.
https://doi.org/10.1158/1078-0432.CCR-09-2487
Published: 14 January 2010
View article titled, A Unifying Microenvironment Model in Follicular Lymphoma: Outcome Is Predicted by Programmed Death-1–Positive, Regulatory, Cytotoxic, and Helper T Cells and Macrophages
Open the PDF for A Unifying Microenvironment Model in Follicular Lymphoma: Outcome Is Predicted by Programmed Death-1–Positive, Regulatory, Cytotoxic, and Helper T Cells and Macrophages in another window